Our study failed to detect the activity of SLC29A1A in AML patients, in whom we inferred SLC29A1 activity from genotype or mRNA expression correlated with Ara-C sensitivity [43]. This evidence concerns the gene SLC29A1 and acute myeloid leukemia.